Abstract
Heat-shock proteins (HSPs), also known as stress proteins, are ubiquitously present in all forms of life. They play pivotal roles in protein folding and unfolding, the formation of multiprotein complexes, the transportation and sorting of proteins into their designated subcellular compartments, the regulation of the cell cycle, and signalling processes. These HSPs encompass HSP27, HSP40, HSP70, HSP60, and HSP90, each contributing to various cellular functions. In the context of cancer, HSPs exert influence by either inhibiting or activating diverse signalling pathways, thereby impacting growth, differentiation, and cell division. This article offers an extensive exploration of the functions of HSPs within the realms of pharmacology and cancer biology. HSPs are believed to play substantial roles in the mechanisms underlying the initiation and progression of cancer. They hold promise as valuable clinical markers for cancer diagnosis, potential targets for therapeutic interventions, and indicators of disease progression. In times of cellular stress, HSPs function as molecular chaperones, safeguarding the structural and functional integrity of proteins and aiding in their proper folding. Moreover, HSPs play a crucial role in cancer growth, by regulating processes such as angiogenesis, cell proliferation, migration, invasion, and metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available in standard research databases such as PubMed, Science Direct, or Google Scholar, and/or on public domains that can be searched with either key words or DOI numbers.
References
Abisambra JF, Blair LJ, Hill SE et al (2010) Phosphorylation dynamics regulate Hsp27-mediated rescue of neuronal plasticity deficits in tau transgenic mice. J Neurosci 30:15374–15382. https://doi.org/10.1523/JNEUROSCI.3155-10.2010
Abu-Hadid M, Wilkes JD, Elakawi Z, et al (1997) Relationship between heat shock protein 60 (HSP60) mR:NA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines. Cancer Lett 119:63–70
Amici R, Bigogno C, Boggio R et al (2014) Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8- dihydro-6H-quinazolin-5-one oxime. ChemMedChem 9:1574–1585. https://doi.org/10.1002/cmdc.201400037
Aoyagi Y, Fujita N, Tsuruo T (2005) Stabilization of integrin-linked kinase by binding to Hsp90. Biochem Biophys Res Commun 331:1061–1068. https://doi.org/10.1016/j.bbrc.2005.03.225
Asgharzadeh F, Moradi-Marjaneh R, Marjaneh MM (2022) The role of heat shock Protein 40 in carcinogenesis and biology of colorectal cancer. Curr Pharm Des 28:1457–1465. https://doi.org/10.2174/1381612828666220513124603
Bao R, Lai CJ, Qu H et al (2009) CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy. Clin Cancer Res 15:4046–4057. https://doi.org/10.1158/1078-0432.CCR-09-0152
Bruey J-M, Ducasse C, Bonniaud P, et al (2000) Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2:645–652
Cai MB, Wang XP, Zhang JX, et al (2012) Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis. J Transl Med 10. https://doi.org/10.1186/1479-5876-10-96
Cappello F, De Macario EC, Marino Gammazza A, et al (2013) ] 626 Hsp60 and human aging: Les liaisons dangereuses. Front Biosci 18:626–637
Castle PE, Ashfaq R, Ansari F, Muller CY (2005) Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix. Cancer Lett 229:245–252. https://doi.org/10.1016/j.canlet.2005.06.045
Cayado-Gutiérrez N, Moncalero VL, Rosales EM et al (2013) Downregulation of Hsp27 (HSPB1) in MCF-7 human breast cancer cells induces upregulation of PTEN. Cell Stress Chaperones 18:243–249. https://doi.org/10.1007/s12192-012-0367-x
Chaiwatanasirikul KA, Sala A (2011) The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60. Cell Death Dis. https://doi.org/10.1038/cddis.2011.99
Chan KC, Ting CM, Chan PS et al (2013) A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation. Mol Cancer. https://doi.org/10.1186/1476-4598-12-128
Chatterjee S, Burns TF (2017) Targeting heat shock proteins in cancer: a promising therapeutic approach. Int J Mol Sci 18:1978
Chen HW, Lee JY, Huang JY et al (2008) Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68:7428–7438. https://doi.org/10.1158/0008-5472.CAN-07-6734
Chen CY, Chiou SH, Huang CY et al (2009) Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma. J Pathol 219:347–355. https://doi.org/10.1002/path.2604
Chengetayi Muchemwa F, Nakatsura T, Fukushima S et al (2008) Differential expression of heat shock protein 105 in melanoma and melanocytic naevi. Wolters Kluwer Health | Lippincott Williams & Wilkins
Cheung KMJ, Matthews TP, James K et al (2005) The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors. Bioorg Med Chem Lett 15:3338–3343. https://doi.org/10.1016/j.bmcl.2005.05.046
Chun JN, Choi B, Lee KW et al (2010) Cytosolic Hsp60 is involved in the NF-kB-dependent survival of cancer cells via IKK regulation. PLoS ONE. https://doi.org/10.1371/journal.pone.0009422
Deng W, Zhang Y, Gu L et al (2016) Heat shock protein 27 downstream of P38-PI3K/Akt signaling antagonizes melatonin-induced apoptosis of SGC-7901 gastric cancer cells. Cancer Cell Int. https://doi.org/10.1186/s12935-016-0283-8
Douglas Hanahan GB, Bergsland E (2000) Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest 105:1045–1047
Edwards DP, Adams DJ, Savage N, Mcguire WL (1980) Biochemical And Biophysical Research Communications Pages 804–812 Estrogen Induced Synthesis Of Specific Proteins In Human Breast Cancer Cells
Ferns G, Shams S, Shafi S (2006) Heat shock protein 27: Its potential role in vascular disease. Int J Exp Pathol 87:253–274
Freshney NW, Rawlinson L, Guesdon F, et al (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphotylation of Hsp27. Cell 78:1039–1049
Fu Wm, ZhangWang JfH et al (2012) Heat shock protein 27 mediates the effect of 1,3,5-trihydroxy-13,13-dimethyl-2H-pyran [7,6-b] xanthone on mitochondrial apoptosis in hepatocellular carcinoma. J Proteomics 75:4833–4843. https://doi.org/10.1016/j.jprot.2012.05.032
Gabai VL, Yaglom JA, Waldman T, Sherman MY (2009) Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol 29:559–569. https://doi.org/10.1128/mcb.01041-08
Gestl EE, Anne Böttger S (2012) Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines. Biochem Biophys Res Commun 423:411–416. https://doi.org/10.1016/j.bbrc.2012.05.139
Ghosh JC, Siegelin MD, Dohi T, Altieri DC (2010) Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res 70:8988–8993. https://doi.org/10.1158/0008-5472.CAN-10-2225
Gomez-Monterrey I, Campiglia P, Scognamiglio I et al (2013) DTNQ-pro, a mimetic dipeptide, sensitizes human colon cancer cells to 5-fluorouracil treatment. J Amino Acids 2013:1–7. https://doi.org/10.1155/2013/509056
Hata M, Ohtsuka K (1998) Characterization of HSE sequences in human Hsp40 gene: structural and promoter analysis. Biochim Biophys Acta 1397:43–55
Hayashi R, Ishii Y, Ochiai H et al (2012) Suppression of heat shock protein 27 expression promotes 5-fluorouracil sensitivity in colon cancer cells in a xenograft model. Oncol Rep 28:1269–1274. https://doi.org/10.3892/or.2012.1935
Heinrich JC, Tuukkanen A, Schroeder M et al (2011) RP101 (Brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients. J Cancer Res Clin Oncol 137:1349–1361. https://doi.org/10.1007/s00432-011-1005-1
Helmbrecht K, Rensing L (1999) Different constitutive heat shock protein 70 expression during proliferation and differentiation of rat C6 glioma cells. Neurochem Res 24:1293–1299
Hosaka S, Nakatsura T, Tsukamoto H et al (2006) Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo. Cancer Sci 97:623–632. https://doi.org/10.1111/j.1349-7006.2006.00217.x
Howe MK, Bodoor K, Carlson DA et al (2014) Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70. Chem Biol 21:1648–1659. https://doi.org/10.1016/j.chembiol.2014.10.016
Izbicka E, Campos D, Carrizales G, Patnaik A (2005) Biomarkers of anticancer activity of R115777 (Tipifarnib, Zarnestraì) in human breast cancer models in vitro. Anticancer Res 25:3215–3224
Jego G, Hermetet F, Girodon F, Garrido C (2020) Chaperoning STAT3/5 by heat shock proteins: interest of their targeting in cancer therapy. Cancers (Basel) 12:21
Ju HQ, Wang SX, Xiang YF et al (2011) BJ-B11, a novel Hsp90 inhibitor, induces apoptosis in human chronic myeloid leukemia K562 cells through the mitochondria-dependent pathway. Eur J Pharmacol 666:26–34. https://doi.org/10.1016/j.ejphar.2011.05.020
Kampinga HH, Hageman J, Vos MJ et al (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14:105–111
Kang SM, Kim SJ, Kim JH et al (2009) Interaction of hepatitis C virus core protein with Hsp60 triggers the production of reactive oxygen species and enhances TNF-α-mediated apoptosis. Cancer Lett 279:230–237. https://doi.org/10.1016/j.canlet.2009.02.003
Kepenekian V, Aloy MT, Magné N et al (2013) Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis. Cell Stress Chaperones 18:623–630. https://doi.org/10.1007/s12192-013-0415-1
Khalouei S, Chow AM, Brown IR (2014) Localization of heat shock protein HSPA6 (HSP70B’) to sites of transcription in cultured differentiated human neuronal cells following thermal stress. J Neurochem 131:743–754. https://doi.org/10.1111/jnc.12970
Kuballa P, Baumann AL, Mayer K et al (2015) Induction of heat shock protein HSPA6 (HSP70B′) upon HSP90 inhibition in cancer cell lines. FEBS Lett 589:1450–1458. https://doi.org/10.1016/j.febslet.2015.04.053
Kumar SJ, Stokes J, Singh UP et al (2016) Targeting Hsp70: a possible therapy for cancer. Cancer Lett 374:156–166
Kuramitsu Y (2012) Heat-shock Protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells. Anticancer Res 32:2295–2299
Leung TKC, Rajendran MY, Monfries C, et al (1990) The human heat-shock protein family Expression of a novel heat-inducible HSP70 (HSP7OB’) and isolation of its cDNA and genomic DNA. Biochem J 267:125–132
Li G, Xu Y, Guan D et al (2011) HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation. J Biol Chem 286:20251–20259. https://doi.org/10.1074/jbc.M110.211771
Li J, Hu W, Lan Q (2012) The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27. J Neurooncol 110:187–194. https://doi.org/10.1007/s11060-012-0963-8
Liffers ST, Maghnouj A, Munding JB et al (2011) Keratin 23, a novel DPC4/Smad4 target gene which binds 14–3–3ε. BMC Cancer. https://doi.org/10.1186/1471-2407-11-137
Lin SP, Lee YT, Wang JY et al (2012) Survival of Cancer Stem Cells under Hypoxia and Serum Depletion via Decrease in PP2A Activity and Activation of p38-MAPKAPK2-Hsp27. PLoS ONE. https://doi.org/10.1371/journal.pone.0049605
Liu QH, Zhao CY, Zhang J et al (2012a) Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses. Mol Med Rep 6:767–773. https://doi.org/10.3892/mmr.2012.1013
Liu T, Jiang W, Han D, Yu L (2012b) DNAJC25 is downregulated in hepatocellular carcinoma and is a novel tumor suppressor gene. Oncol Lett 4:1274–1280. https://doi.org/10.3892/ol.2012.903
Lu Z, Jin Y, Qiu L et al (2010) Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. Cancer Lett 290:182–191. https://doi.org/10.1016/j.canlet.2009.09.006
Lu X, Xiao L, Wang L, Ruden DM (2012) Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs. Biochem Pharmacol 83:995–1004
Lv LH, Le WY, Lin Y et al (2012) Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem 287:15874–15885. https://doi.org/10.1074/jbc.M112.340588
Mahoney SE, Yao Z, Keyes CC et al (2012) Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas. Epigenetics 7:400–408. https://doi.org/10.4161/epi.19463
Mathias RA, Guise AJ, Cristea IM, Laboratory LT (2015) Post-translational modifications regulate class IIa histone deacetylase function in health and disease. MCP Papers (in press)
Menezes ME, Mitra A, Shevde LA, Samant RS (2012) DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity. Biochem J 444:573–580. https://doi.org/10.1042/BJ20120205
Mitra A, Fillmore RA, Metge BJ et al (2008) Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res. https://doi.org/10.1186/bcr1874
Mitra A, Menezes ME, Shevde LA, Samant RS (2010) DNAJB6 induces degradation of β-catenin and causes partial reversal of mesenchymal phenotype. J Biol Chem 285:24686–24694. https://doi.org/10.1074/jbc.M109.094847
Miyata Y, Nakamoto H, Neckers L (2012) The Therapeutic Target Hsp90 and Cancer Hallmarks. Curr Pharm Des 19:347–365. https://doi.org/10.2174/138161213804143725
Moretti-Rojas I, Fuqua SAW, Iii RAM, Mcguire WL (1988) A cDNA for the estradiol-regulated 24K protein: control of mRNA levels in MCF-7 cells. Breast Cancer Res Treat 11:155–163
Moses MA, Henry EC, Ricke WA, Gasiewicz TA (2015) The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model. Cancer Prev Res 8:249–257. https://doi.org/10.1158/1940-6207.CAPR-14-0224
Murphy ME (2013) The HSP70 family and cancer. Carcinogenesis 34:1181–1188. https://doi.org/10.1093/carcin/bgt111
Nagaraju GP, Long TE, Park W et al (2015) Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer. Mol Carcinog 54:1147–1158. https://doi.org/10.1002/mc.22185
Nomura M, Nomura N, Newcomb EW et al (2004) Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells. J Cell Physiol 201:374–384. https://doi.org/10.1002/jcp.20090
Nylandsted J, Gyrd-Hansen M, Danielewicz A et al (2004) Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 200:425–435. https://doi.org/10.1084/jem.20040531
O’Callaghan-Sunol C, Gabai VL, Sherman MY (2007) Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 67:11779–11788. https://doi.org/10.1158/0008-5472.CAN-07-2441
Ono N, Yamazaki T, Nakanishi Y et al (2012) Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers. Cancer Sci 103:342–349. https://doi.org/10.1111/j.1349-7006.2011.02144.x
Pace A, Barone G, Lauria A, et al (2013) Send Orders of Reprints at reprints@benthamscience.net Current Pharmaceutical Design
Prodromou C, Pearl LH (2003) Structure and functional relationships of Hsp90. Curr Cancer Drug Targets 3:301–323
Qiu XB, Shao YM, Miao S, Wang L (2006) The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol Life Sci 63:2560–2570
Radons J (2016) The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones 21:379–404
Rajan A, Kelly RJ, Trepel JB et al (2011) A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas. Clin Cancer Res 17:6831–6839. https://doi.org/10.1158/1078-0432.CCR-11-0821
Ramirez VP, Krueger W, Aneskievich BJ (2015) TNIP1 reduction of HSPA6 gene expression occurs in promoter regions lacking binding sites for known TNIP1-repressed transcription factors. Gene 555:430–437. https://doi.org/10.1016/j.gene.2014.11.012
Regeling A, Imhann F, Volders HH et al (2016) HSPA6 is an ulcerative colitis susceptibility factor that is induced by cigarette smoke and protects intestinal epithelial cells by stabilizing anti-apoptotic Bcl-XL. Biochim Biophys Acta Mol Basis Dis 1862:788–796. https://doi.org/10.1016/j.bbadis.2016.01.020
Rober S et al (1995) Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent*. Springer-Verlag
Ruan W, Wang Y, Ma Y et al (2010) HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma. J Exp Clin Cancer Res. https://doi.org/10.1186/1756-9966-29-41
Seggewiss-Bernhardt R, Bargou RC, Goh YT et al (2015) Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma. Cancer 121:2185–2192
Sharma A, Upadhyay AK, Bhat MK (2009) Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells. Cancer Biol Ther 8:2106–2113. https://doi.org/10.4161/cbt.8.22.9687
Shi Y, Liu X, Lou J et al (2014) Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses. Clin Cancer Res 20:6016–6022. https://doi.org/10.1158/1078-0432.CCR-14-0174
Shi J, Fu M, Zhao C et al (2016) Characterization and function analysis of Hsp60 and Hsp10 under different acute stresses in black tiger shrimp, Penaeus monodon. Cell Stress Chaperones 21:295–312. https://doi.org/10.1007/s12192-015-0660-6
Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2:1097–1105. https://doi.org/10.1177/1947601911423031
Shiota M, Bishop JL, Nip KM et al (2013) Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. Cancer Res 73:3109–3119. https://doi.org/10.1158/0008-5472.CAN-12-3979
Sigler PB, Xu Z, Rye HS, et al (1998) Structure and function in groel-mediated protein folding
Sims JT, Ganguly SS, Bennett H et al (2013) Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1. PLoS ONE. https://doi.org/10.1371/journal.pone.0055509
Slotta-Huspenina J, Wolff C, Drecoll E et al (2013) A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas. Br J Cancer 109:370–378. https://doi.org/10.1038/bjc.2013.319
Starenki D, Hong SK, Lloyd RV, Park JI (2015) Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Oncogene 34:4624–4634. https://doi.org/10.1038/onc.2014.392
Sterrenberg JN, Blatch GL, Edkins AL (2011) Human DNAJ in cancer and stem cells. Cancer Lett 312:129–142
Stetler RA, Gao Y, Signore AP, et al (2009) HSP27: mechanisms of cellular protection against neuronal injury. Curr Mol Med 9:863–872
Takahashi K, Tanaka M, Yashiro M et al (2016) Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells. Cancer Lett 378:8–15. https://doi.org/10.1016/j.canlet.2016.05.002
Tokunaga Y, Otsuyama KI, Kakuta S, Hayashida N (2022) Heat shock transcription factor 2 Is significantly involved in neurodegenerative diseases, inflammatory bowel disease, cancer, male infertility, and fetal alcohol spectrum disorder: the novel mechanisms of several severe diseases. Int J Mol Sci 23:13763
Trinh DLN, Elwi AN, Kim S-W (2010) Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis. Oncotarget 1:396
Tsai MF, Wang CC, Chang GC et al (2006) A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 98:825–838. https://doi.org/10.1093/jnci/djj229
Tsai YP, Teng SC, Wu KJ (2008) Direct regulation of HSP60 expression by c-MYC induces transformation. FEBS Lett 582:4083–4088. https://doi.org/10.1016/j.febslet.2008.11.004
Tsai YP, Yang MH, Huang CH et al (2009) Interaction between HSP60 and β-catenin promotes metastasis. Carcinogenesis 30:1049–1057. https://doi.org/10.1093/carcin/bgp087
Tsutsumi S, Scroggins B, Koga F et al (2008) A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 27:2478–2487. https://doi.org/10.1038/sj.onc.1210897
Wachsberger PR, Lawrence YR, Liu Y et al (2014) Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma. J Cancer Res Clin Oncol 140:573–582. https://doi.org/10.1007/s00432-014-1594-6
Wadhwa R, Takano S, Kaur K et al (2005) Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60. Biochem J 391:185–190. https://doi.org/10.1042/BJ20050861
Wang XY, Subjeck JR (2013) High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy. Int J Hyperth 29:364–375. https://doi.org/10.3109/02656736.2013.803607
Wang CC, Tsai MF, Hong TM et al (2005) The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 24:4081–4093. https://doi.org/10.1038/sj.onc.1208573
Wang CC, Liao YP, Mischel PS et al (2006) HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Cancer Res 66:6756–6762. https://doi.org/10.1158/0008-5472.CAN-06-0185
Wang X, Wang Q, Lin H (2010) Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human esophageal squamous cell carcinoma. Clin Dev Immunol. https://doi.org/10.1155/2010/212537
Wang X, Chen M, Zhou J, Zhang X (2014) HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (review). Int J Oncol 45:18–30
Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761–772
Wu J, Liu T, Rios Z et al (2017) Heat shock proteins and cancer. Trends Pharmacol Sci 38:226–256
Xu L, Bergan RC (2006) Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor β-mediated activation of mitogen-activated protein kinase-activated protein kinase 2–27-kDa heat shock protein pathway. Mol Pharmacol 70:869–877. https://doi.org/10.1124/mol.106.023861
Yang Z, Zhuang L, Szatmary P et al (2015) Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma. Int J Med Sci 12:256–263. https://doi.org/10.7150/ijms.10735
Yoshidomi K, Murakami A, Yakabe K et al (2014) Heat shock protein 70 is involved in malignant behaviors and chemosensitivities to cisplatin in cervical squamous cell carcinoma cells. J Obstet Gynaecol Res 40:1188–1196. https://doi.org/10.1111/jog.12325
Yun CW, Kim HJ, Lim JH, Lee SH (2020) Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy. Cells 9:60
Zackova M, Mouckova D, Lopotova T et al (2013) Hsp90—a potential prognostic marker in CML. Blood Cells Mol Dis 50:184–189. https://doi.org/10.1016/j.bcmd.2012.11.002
Zanini C, Pulera F, Carta F et al (2008) Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing’s sarcoma. Virchows Arch 452:157–167. https://doi.org/10.1007/s00428-007-0549-6
Zhang L, Cai X, Chen K et al (2011) Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells. Virus Res 157:76–81. https://doi.org/10.1016/j.virusres.2011.02.009
Zhang S, Hu Y, Huang Y et al (2015) Heat shock protein 27 promotes cell proliferation through activator protein-1 in lung cancer. Oncol Lett 9:2572–2576. https://doi.org/10.3892/ol.2015.3073
Zuo D, Subjeck J, Wang XY (2016) Unfolding the role of large heat shock proteins: new insights and therapeutic implications. Front Immunol 7:75
Acknowledgements
I wholeheartedly thank JSS College of Pharmacy, Mysuru for providing the facilities during the manuscript preparation. I want to express my gratitude to Biorender.com (free trial version) for enabling the creation of all the figures.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
YMT, DT, TES, VJ, AHR, SKM, AB, and AB made significant contribution to the work reported, whether that is in the conception, execution, or the acquisition, analysis, or interpretation of data, or all the areas; took part in drafting, revising, or critically reviewing the article; and gave final approval of the version to be published. All have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Research involving human participants and/or animals
Not involved human participants and/or animals.
Informed consent
Not involved human participants so not applicable.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tausif, Y.M., Thekkekkara, D., Sai, T.E. et al. Heat shock protein paradigms in cancer progression: future therapeutic perspectives. 3 Biotech 14, 96 (2024). https://doi.org/10.1007/s13205-024-03951-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-024-03951-6